AXA S.A. - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
AXA S.A. ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$2,602,000
-6.9%
756,356
-0.2%
0.01%0.0%
Q2 2019$2,796,000
-28.1%
757,690
+104.4%
0.01%
-66.7%
Q1 2019$3,888,000
+1.0%
370,6210.0%0.02%
-11.8%
Q4 2018$3,851,000
-13.8%
370,6210.0%0.02%
+6.2%
Q3 2018$4,466,000
+1.7%
370,6210.0%0.02%
-5.9%
Q2 2018$4,392,000
+8.2%
370,621
+40.5%
0.02%
+6.2%
Q1 2018$4,058,000
+13.3%
263,880
-1.0%
0.02%
+14.3%
Q4 2017$3,583,000
-14.1%
266,585
+7.6%
0.01%
-22.2%
Q3 2017$4,172,000
+44.2%
247,726
+15.9%
0.02%
+38.5%
Q2 2017$2,894,000213,7220.01%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders